Skip to main content
OpenTrials
Completed

NCT Number: NCT03583398

Health-related QoL Following TAVI TAo, TAVI TF and AVR

The aim of the study was to evaluate short- and long-term changes in QoL in patients undergoing TAVI and to assess differences in patient QoL when using the TAVI TAo approach compared with the transfemoral approach (TAVI TF) and surgical aortic valve replacement (SAVR).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aortic valve stenosis

Exclusion criteria

-

Treatment and study plan

transcatheter aortic valve implantation, surgical aortic valve replacement

Procedure

Transcatheter aortic valve implantation using transaortic and transfemoral access and surgical aortic valve replacement.

Primary outcomes

  1. Health-related quality of life: EQ-5D-3L questionnaire

    Time frame: 1 month and 1 year follow-up

    EQ-5D-3L questionnaire

Sponsors and collaborators

Lead sponsor

Medical University of Gdansk

Other

Collaborators

  • Institut für Pharmakologie und Präventive Medizin

Registry information

Official study title

Health-related Quality of Life Following Transcatheter Aortic Valve Implantation Using Transaortic, Transfemoral Approaches and Surgical Aortic Valve Replacement - a Single-center Study

Important dates

Study start
2015
Primary completion
2017
Study completion
2018
First posted
Jul 11, 2018
Registry last updated
Jul 12, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.